Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris-Reference-Cited by-同舟云学术

Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris

Published:2021-12-22 Issue:3 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Li Jizhou¹²,Coste Alix T.¹,Bachmann Daniel¹,Sanglard Dominique¹^ORCID,Lamoth Frederic¹²^ORCID

Affiliation:

1. Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

2. Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Abstract

Candida auris is emerging as a major public health threat because of its ability to cause nosocomial outbreaks of severe invasive candidiasis. Management of C. auris infection is difficult because of its frequent multidrug-resistant profile for currently licensed antifungals.

Funder

Fondation Santos-Suarez pour la Recherche Médicale

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.01395-21

Reference20 articles.

1. A Candida auris Outbreak and Its Control in an Intensive Care Setting

2. Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

3. First hospital outbreak of the globally emerging Candida auris in a European hospital